V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006592 | 310007535 | 1.61 | 59.3 | Palliative (P) | 2014-02-26 | 2014-03-05 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310007508 | LIPOSOMAL DOXORUBICIN |
| 310006594 | 310003766 | 1.78 | 91.2 | Palliative (P) | 2016-05-27 | 2016-06-18 | GemCarbo Days 1+8 | N | N | 310007512 | GEMCARBO |
| 310006595 | 310003768 | 1.68 | 77 | Palliative (P) | 2013-09-01 | 2013-09-16 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310007518 | LIPOSOMAL DOXORUBICIN |
| 310006596 | 310003770 | 1.49 | 66 | Palliative (P) | 2013-11-03 | 2013-12-13 | Trial Unspecified | N | N | 310007520 | TRIAL |
| 310006597 | 310003772 | 1.67 | 82 | Palliative (P) | 2013-07-01 | 2013-08-16 | Bevacizumab | N | N | 310007520 | BEVACIZUMAB |
| 310006598 | 310003775 | 1.73 | 86.2 | Neo-adjuvant (N) | 2016-10-17 | 2016-10-19 | GemCarbo Days 1+8 | N | N | 310007534 | GEMCARBO |
| 310006599 | 310003776 | 1.49 | 77.3 | Palliative (P) | 2014-02-28 | 2014-03-03 | Bevacizumab 7.5mg/kg | 2 | Y | 310007538 | BEVACIZUMAB |
| 310006600 | 310007542 | 1.72 | null | Palliative (P) | 2013-08-31 | 2013-09-07 | GemCarbo Days 1+8 | N | N | 310007540 | GEMCARBO |
| 310006601 | 310003778 | 1.8 | 53.3 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-30 | Bevacizumab 7.5mg/kg | 02 | N | 310007540 | BEVACIZUMAB |
| 310006602 | 310007544 | 1.71 | 85.21 | null | 2017-07-21 | 2017-08-25 | Trial Unspecified | N | null | 310007548 | TRIAL |
| 310006603 | 310003782 | 1.61 | 81.6 | Curative (C) | 2017-02-14 | 2017-02-14 | Trial Unspecified | N | N | 310007550 | TRIAL |
| 310006604 | 310003783 | 1.83 | 62.6 | Palliative (P) | 2013-05-21 | 2013-06-05 | CHOP - 21 days | N | N | 310007554 | CHOP |
| 310006605 | 310003786 | 1.75 | 107.5 | Palliative (P) | 2015-05-08 | 2015-06-10 | Trial Unspecified | 1 | N | 310007565 | TRIAL |
| 310006606 | 310003788 | 1.8 | null | Palliative (P) | 2013-07-14 | 2013-07-23 | Trial Unspecified | 02 | N | 310007566 | TRIAL |
| 310006607 | 310007546 | 1.76 | 78.6 | null | 2017-09-14 | 2017-10-15 | Trial Unspecified | 01 | N | 310007567 | TRIAL |
| 310006608 | 310007546 | 1.47 | 0 | Palliative (P) | null | 2013-11-08 | CHOP - 21 days | 02 | N | 310007567 | CHOP |
| 310006609 | 310003791 | null | null | Adjuvant (A) | null | 2017-04-07 | Bevacizumab | 02 | N | 310007572 | BEVACIZUMAB |
| 310006610 | 310003791 | null | 124.9 | Neo-adjuvant (N) | 2017-10-03 | 2017-10-12 | CHOP | 02 | Y | 310007572 | CHOP |
| 310006611 | 310003792 | 1.5 | null | Palliative (P) | 2017-02-14 | 2017-08-22 | EW EuroEwing 2012 Arm B VDC | 01 | N | 310007577 | TRIAL |
| 310006612 | 310010577 | 1.63 | 76 | Palliative (P) | 2017-09-24 | 2017-10-01 | GEMCARBO | N | N | 310007578 | GEMCARBO |
| 310006613 | 310003795 | 1.62 | null | Curative (C) | null | 2015-11-07 | CHOP - 14 days | 02 | N | 310007583 | CHOP |
| 310006614 | 310003796 | 1.86 | 82.7 | Palliative (P) | 2012-06-19 | 2015-06-22 | Bevacizumab | N | N | 310007583 | BEVACIZUMAB |
| 310006615 | 310003797 | 1.57 | 68.9 | Adjuvant (A) | 2015-01-08 | 2015-01-08 | Trial Unspecified | Y | N | 310007587 | TRIAL |
| 310006616 | 310003797 | 1.78 | 107.5 | Palliative (P) | 2016-02-09 | 2016-08-17 | Trial Unspecified | N | N | 310007587 | TRIAL |
| 310006617 | 310003797 | 1.65 | null | null | null | 2015-04-19 | Trial Unspecified | 02 | null | 310007587 | TRIAL |
| 310006618 | 310003797 | 1.72 | 93 | null | 2018-01-19 | 2018-07-15 | Trial Unspecified | 2 | N | 310007587 | TRIAL |
| 310006619 | 310003798 | 1.75 | null | Palliative (P) | 2016-12-01 | 2016-12-29 | GemCarbo Days 1+8 | N | N | 310007593 | GEMCARBO |
| 310006620 | 310003799 | 1.82 | 71 | Palliative (P) | 2013-07-19 | 2013-08-10 | Liposomal Doxorubicin (Caelyx) | N | null | 310007594 | LIPOSOMAL DOXORUBICIN |
| 310006621 | 310003800 | 1.83 | 73 | Palliative (P) | 2015-11-11 | 2015-11-12 | Trial Unspecified | Y | N | 310007610 | TRIAL |
| 310006622 | 310003801 | 1.63 | 82.6 | Palliative (P) | 2017-03-05 | 2017-03-09 | CARBOPLATIN + GEMCITABINE | N | N | 310007613 | GEMCARBO |
| 310006623 | 310007556 | 1.8 | null | Palliative (P) | 2017-11-06 | 2017-11-16 | CHOP - 21 days | N | N | 310007616 | CHOP |
| 310006624 | 310003804 | 1.85 | 86 | Palliative (P) | 2015-08-10 | 2015-11-19 | Bevacizumab | 02 | N | 310007616 | BEVACIZUMAB |
| 310006625 | 310003805 | 1.91 | 104 | Palliative (P) | 2014-06-21 | 2014-07-19 | LIPOSOMAL DOXORUBICIN | 02 | N | 310007627 | LIPOSOMAL DOXORUBICIN |
| 310006626 | 310003806 | 1.62 | 68.6 | Palliative (P) | 2015-04-12 | 2015-07-13 | Trial Unspecified | 01 | null | 310007646 | TRIAL |
| 310006627 | 310003808 | 1.6 | 54.55 | Curative (C) | null | 2017-09-29 | CHOP - 21 days | 02 | N | 310007651 | CHOP |
| 310006628 | 310007560 | 1.6 | 44.4 | Palliative (P) | 2013-12-29 | 2014-01-02 | Bevacizumab 15mg/kg | 02 | N | 310007651 | BEVACIZUMAB |
| 310006629 | 310003813 | 1.57 | 77.9 | Palliative (P) | 2016-02-14 | 2016-03-14 | Bevacizumab 15mg/kg | 02 | N | 310007676 | BEVACIZUMAB |
| 310006630 | 310009529 | 1.62 | null | Palliative (P) | 2014-04-21 | 2014-04-21 | Bevacizumab 7.5mg/kg | 02 | N | 310007685 | BEVACIZUMAB |
| 310006631 | 310009529 | 1.81 | null | Palliative (P) | 2017-04-07 | 2018-01-27 | Trial Unspecified | 01 | N | 310007685 | TRIAL |
| 310006632 | 310009529 | 1.85 | 104 | Not known (9) | 2013-09-18 | 2013-11-05 | CHOP - 21 days | N | N | 310007685 | CHOP |
| 310006633 | 310003814 | 1.34 | 72.4 | Palliative (P) | 2014-04-22 | 2014-09-06 | Bevacizumab 7.5mg/kg | N | N | 310007688 | BEVACIZUMAB |
| 310006634 | 310007563 | 1.78 | 66 | Palliative (P) | 2018-04-08 | 2018-04-10 | CHOP - 21 days | N | N | 310007713 | CHOP |
| 310006635 | 310009530 | 1.84 | null | null | null | 2017-10-17 | CHOP - 21 days | N | N | 310007714 | CHOP |
| 310006636 | 310003816 | 1.74 | null | Curative (C) | 2016-05-25 | 2016-05-28 | Trial Unspecified | Y | N | 310007734 | TRIAL |
| 310006637 | 310003817 | null | 60 | Palliative (P) | 2016-07-28 | 2016-08-01 | Bevacizumab 7.5mg/kg | 2 | N | 310007768 | BEVACIZUMAB |
| 310006638 | 310003820 | 1.64 | 72.3 | Palliative (P) | 2017-02-17 | 2017-02-24 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE PREDNISOLONE | N | N | 310007768 | CHOP |
| 310006639 | 310003821 | 1.58 | 94.3 | Neo-adjuvant (N) | 2013-04-30 | 2013-06-16 | CHOP | 02 | N | 310007769 | CHOP |
| 310006640 | 310003821 | 1.28 | 72 | Curative (C) | 2013-10-12 | 2013-11-23 | CHOP - 21 days | N | N | 310007769 | CHOP |
| 310006641 | 310003821 | 1.73 | 74.9 | Adjuvant (A) | 2016-09-01 | 2016-09-04 | Bevacizumab 7.5mg/kg | 2 | N | 310007769 | BEVACIZUMAB |
| 310006645 | 310003826 | 1.7 | 20 | Neo-adjuvant (N) | 2018-07-03 | 2018-07-03 | GEMCARBO | 2 | N | 310007894 | GEMCARBO |